- Home
- SRFM vs TVGN Comparison
SRFM vs TVGN Comparison
Compare SRFM & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- TVGN
- Stock Information
- Founded
- SRFM 2011
- TVGN 2020
- Country
- SRFM United States
- TVGN United States
- Employees
- SRFM N/A
- TVGN N/A
- Industry
- SRFM Transportation Services
- TVGN Blank Checks
- Sector
- SRFM Consumer Discretionary
- TVGN Finance
- Exchange
- SRFM Nasdaq
- TVGN Nasdaq
- Market Cap
- SRFM 191.9M
- TVGN 179.0M
- IPO Year
- SRFM 2023
- TVGN N/A
- Fundamental
- Price
- SRFM $3.52
- TVGN $0.53
- Analyst Decision
- SRFM Buy
- TVGN Strong Buy
- Analyst Count
- SRFM 4
- TVGN 1
- Target Price
- SRFM $5.75
- TVGN $10.00
- AVG Volume (30 Days)
- SRFM 3.0M
- TVGN 518.9K
- Earning Date
- SRFM 11-12-2025
- TVGN 11-19-2025
- Dividend Yield
- SRFM N/A
- TVGN N/A
- EPS Growth
- SRFM N/A
- TVGN N/A
- EPS
- SRFM N/A
- TVGN N/A
- Revenue
- SRFM $107,372,000.00
- TVGN N/A
- Revenue This Year
- SRFM N/A
- TVGN N/A
- Revenue Next Year
- SRFM $18.06
- TVGN N/A
- P/E Ratio
- SRFM N/A
- TVGN N/A
- Revenue Growth
- SRFM N/A
- TVGN N/A
- 52 Week Low
- SRFM $1.50
- TVGN $0.51
- 52 Week High
- SRFM $9.91
- TVGN $2.07
- Technical
- Relative Strength Index (RSI)
- SRFM 35.19
- TVGN 28.65
- Support Level
- SRFM $3.41
- TVGN $0.58
- Resistance Level
- SRFM $4.09
- TVGN $0.63
- Average True Range (ATR)
- SRFM 0.27
- TVGN 0.04
- MACD
- SRFM -0.12
- TVGN -0.01
- Stochastic Oscillator
- SRFM 6.94
- TVGN 6.25
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.